MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The discrepancy between self-reported hyposmia and objective assessment by Sniffin’ sticks in high risk of synucleinopathies and healthy controls.

J. Sringean, S. Phumphid, C. Anan, J. Meesri, P. Rattanajun, S. Wehhinhiran, A. Chantadunga, T. Sanengmanee, R. Bhidayasiri (Bangkok, Thailand)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms (non-Cognitive/ non-Psychiatric)

Objective: To study the discrepancy between self-reported hyposmia and the objective assessment of Sniffin’ sticks (identification subset, SS-16) in high risk of synucleinopathy and healthy controls.

Background: Hyposmia strongly predicts Parkinson’s disease (PD) phenoconversion, with a 3.8-fold increased risk, often appearing as the earliest prodromal symptom over 20 years before diagnosis. Smell identification tests, varying in sensitivity and specificity, support early detection efforts. Screening questions offer a practical first step for community-based PD screening programs.

Method: In the CheckPD digital screening project, 677 participants aged over 40 were enrolled. Of these, 159 identified as high-risk via the application were further assessed using the RBD-HK questionnaire, MoCA test, MDS-UPDRS III, and SS-16. They were divided into high-risk/new diagnosis of early PD (n=107) and healthy (n=52) groups based on criteria including positive RBD-HK results, or 2 of self-reported symptoms (e.g., acting out dreams, constipation, hyposmia, depression), or 1 self-reported symptoms plus with either mild parkinsonian signs, or a first-degree PD family history. McNemar’s Test evaluated discrepancies between self-reported hyposmia and objective SS-16 assessments.

Results: Demographic data and assessment scores are presented in Table 1 [table 1]. SS-16 scores differed significantly between high-risk participants (9.7 ± 3.0) and healthy controls (11.4 ± 1.2, p < 0.001). Among 159 participants, those with normal SS-16 smell reported “No” (84) or “Yes” (19) to the screening question, while hyposmic participants reported “No” (41) or “Yes” (15), showing a significant discrepancy (p = 0.007). In the high-risk and early PD group, normal smell responses were “No” (50) or “Yes” (14), and hyposmic responses were “No” (31) or “Yes” (12; p = 0.017). Healthy controls reported “No” (34) or “Yes” (5) for normal smell and “No” (10) or “Yes” (3) for hyposmia (p = 0.302) [table 2], [figure 2].

Conclusion: Our study shows that while the screening question identifies some individuals with smell loss, it frequently underdetects hyposmia, particularly in populations at risk or in early stages of PD.This discrepancy highlights the limitations of subjective screening tools and objective olfactory testing remains essential for accurate identification of hyposmia.

Figure 1

Figure 1

Table 1

Table 1

Table 2

Table 2

References: Bhidayasiri R,et al. The rise of Parkinson’s disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and “eat, move, sleep” lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand. Front Neurol. 2024 May 13;15:1386608. doi: 10.3389/fneur.2024.1386608. PMID: 38803644; PMCID: PMC11129688.

Schaeffer E, Postuma RB, Berg D. Prodromal PD: A new nosological entity. Prog Brain Res. 2020;252:331-356. doi: 10.1016/bs.pbr.2020.01.003. Epub 2020 Feb 10. PMID: 32247370.
Sui X, Zhou C, Li J, Chen L, Yang X, Li F. Hyposmia as a Predictive Marker of Parkinson’s Disease: A Systematic Review and Meta-Analysis. Biomed Res Int. 2019 May 19;2019:3753786. doi: 10.1155/2019/3753786. PMID: 31236405; PMCID: PMC6545790.

Fujio H, Inokuchi G, Tatehara S, Kuroki S, Fukuda Y, Kowa H, Nibu KI. Characteristics of Smell Identification Test in Patients With Parkinson Disease. Clin Exp Otorhinolaryngol. 2019 May;12(2):206-211. doi: 10.21053/ceo.2018.01116. Epub 2018 Dec 27. PMID: 30586953; PMCID: PMC6453781.

Trentin S, Fraiman de Oliveira BS, Ferreira Felloni Borges Y, de Mello Rieder CR. Systematic review and meta-analysis of Sniffin Sticks Test performance in Parkinson’s disease patients in different countries. Eur Arch Otorhinolaryngol. 2022 Mar;279(3):1123-1145. doi: 10.1007/s00405-021-06970-8. Epub 2021 Jul 28. PMID: 34319482.

To cite this abstract in AMA style:

J. Sringean, S. Phumphid, C. Anan, J. Meesri, P. Rattanajun, S. Wehhinhiran, A. Chantadunga, T. Sanengmanee, R. Bhidayasiri. The discrepancy between self-reported hyposmia and objective assessment by Sniffin’ sticks in high risk of synucleinopathies and healthy controls. [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/the-discrepancy-between-self-reported-hyposmia-and-objective-assessment-by-sniffin-sticks-in-high-risk-of-synucleinopathies-and-healthy-controls/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-discrepancy-between-self-reported-hyposmia-and-objective-assessment-by-sniffin-sticks-in-high-risk-of-synucleinopathies-and-healthy-controls/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley